中文 | English
Return
Total: 5 , 1/1
Show Home Prev Next End page: GO
MeSH:(Bone Density Conservation Agents/adverse effects/*therapeutic use)

2.Comparison of Effect of Treatment with Etidronate and Alendronate on Lumbar Bone Mineral Density in Elderly Women with Osteoporosis.

Jun IWAMOTO ; Tsuyoshi TAKEDA ; Yoshihiro SATO ; Mitsuyoshi UZAWA

Yonsei Medical Journal 2005;46(6):750-758

3.A Prospective, Multicenter, Open-label Trial of Zoledronic Acid in Patients with Hormone Refractory Prostate Cancer.

Sung Joon HONG ; Kang Su CHO ; Han Yong CHO ; Hanjong AHN ; Choung Soo KIM ; Byung Ha CHUNG

Yonsei Medical Journal 2007;48(6):1001-1008

4.The Effect of Zoledronic Acid on the Volume of the Fusion-Mass in Lumbar Spinal Fusion.

Ye Soo PARK ; Hong Sik KIM ; Seung Wook BAEK ; Dong Yi KONG ; Jeong Ah RYU

Clinics in Orthopedic Surgery 2013;5(4):292-297

5.Are glucocorticoid-induced osteoporosis recommendations sufficient to determine antiosteoporotic treatment for patients with rheumatoid arthritis?.

Joo Hyun LEE ; Soo Kyung CHO ; Minkyung HAN ; Dam KIM ; Sang Cheol BAE ; Yoon Kyoung SUNG

The Korean Journal of Internal Medicine 2014;29(4):509-515

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 5 , 1/1 Show Home Prev Next End page: GO